Page 26 - Service Testing News Today

By Ben Glickman Shares of ALX Oncology rose Monday after the company said it would discuss interim Phase 2 trial results on a call Tuesday. The stock was up...

By Colin Kellaher AbbVie on Friday said a Phase 3 study evaluating the safety and efficacy of its venetoclax cancer drug in combination with dexamethasone...

Analysts say that the arrival of cheaper, more convenient obesity pills could mean much broader access for patients, and eventually a larger market.

By Ben Glickman Shares of Syndax Pharmaceuticals rose after the company said it would announce results from its clinical trial Oct. 2. The stock was up 15%...

VBI Vaccines' stock soars 8% in early trade.

By Dean Seal Shares of Immunovant surged after the company disclosed positive results from a Phase 1 clinical trial of its IMVT-1402 drug candidate for...

By Dean Seal Shares of Pliant Therapeutics surged after the company said the clinical trial of its lead product candidate bexotegrast met its primary and...

By Josh Beckerman Cardiff Oncology shares rose 10% to $1.78 after hours as the company reported favorable data for onvansertib from ongoing trials in...

By Sabela Ojea Shares of BioVie on Tuesday climbed after the company said the last of 400 patients completed treatment in its multicenter phase 3 study to...

Should any seriously ill person be able to get promising but unapproved drugs? The answers to this and other questions may be more complicated than you think.